Found: 16
Select item for more details and to access through your institution.
Past, Present, and a Glance into the Future of Multiple Myeloma Treatment.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 3, p. 415, doi. 10.3390/ph16030415
- By:
- Publication type:
- Article
Bruton's Tyrosine Kinase Targeting in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5707, doi. 10.3390/ijms22115707
- By:
- Publication type:
- Article
SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 1, p. 156, doi. 10.3390/jcm10010156
- By:
- Publication type:
- Article
TRAIL Dependent Fratricidal Killing of gp120 Primed Hepatocytes by HCV Core Expressing Hepatocytes.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027171
- By:
- Publication type:
- Article
Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2576, doi. 10.3390/cancers12092576
- By:
- Publication type:
- Article
miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 1, p. 180, doi. 10.1002/1878-0261.12588
- By:
- Publication type:
- Article
Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1.
- Published in:
- EMBO Journal, 2012, v. 31, n. 3, p. 576, doi. 10.1038/emboj.2011.434
- By:
- Publication type:
- Article
Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.
- Published in:
- Cellular & Molecular Life Sciences, 2019, v. 76, n. 10, p. 1947, doi. 10.1007/s00018-019-03053-0
- By:
- Publication type:
- Article
Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 6, p. 1, doi. 10.1038/s41419-024-06791-7
- By:
- Publication type:
- Article
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01562-9
- By:
- Publication type:
- Article
The Transcribed-Ultra Conserved Regions: Novel Non-Coding RNA Players in Neuroblastoma Progression.
- Published in:
- Non-Coding RNA, 2019, v. 5, n. 2, p. 1, doi. 10.3390/ncrna5020039
- By:
- Publication type:
- Article
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges.
- Published in:
- Theranostics, 2021, v. 11, n. 2, p. 731, doi. 10.7150/thno.51471
- By:
- Publication type:
- Article
A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02530-y
- By:
- Publication type:
- Article
Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 7, p. 1, doi. 10.1093/jnci/djv135
- By:
- Publication type:
- Article
Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article